Sold as Bensulfoid. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Sulfur (sold as Bensulfoid), first approved Sep 17, 1940, with 0 new uses approved and 0 published complete response letters.
| Effects of Hypoxia or Caffeine on 4km Time-trial Morning Cycling.Caffeine, Hypoxia · Liverpool John Moores University | Phase 4 | Recruiting | Nov 13, 2026 |
| Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial StenosisIschemic Stroke, Symptomatic Intracranial Atherosclerotic Stenosis · Second Affiliated Hospital of Soochow University | Phase 4 | Recruiting | Nov 12, 2026 |
| Ceftazidime Safety and Efficacy in the Prevention of Surgical Site InfectionsThoracolumbar Spinal Fusion · University of Utah | Phase 2 | Enrolling by invitation | Nov 12, 2026 |
| Disulfiram for Preventing Treatment Complications in Patients Undergoing CAR T-cell Therapy for Relapsed or Refractory Diffuse Large B-cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma · University of Michigan Rogel Cancer Center | Phase 1 / Phase 2 | Not yet recruiting | Nov 12, 2026 |
| Alpha-Lipoic Acid Added to Dapagliflozin and Insulin Resistance in Type 2 DiabetesDiabetes Mellitus, Type 2, Insulin Resistance Syndrome · Fayoum University | Phase 3 | Not yet recruiting | Nov 12, 2026 |
| A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsHypercholesterolemia · AstraZeneca | Phase 3 | Not yet recruiting | Nov 12, 2026 |
| Magnesium-Enhanced ESPB for Respiratory Recovery and Analgesia in Unilateral Rib FracturesUnilateral Rib Fracture, ESPB · Assiut University | Not applicable | Not yet recruiting | Nov 10, 2026 |
| To Evaluate The Efficacy And Safety Of Rivaroxaban In Combination With Aspirin Compared With Aspirin Monotherapy In Patients With Stable Coronary Artery Disease (CAD) and High Ischemic RiskStable Coronary Artery Disease (CAD), Myocardial Infarction · Republican Specialized Scientific and Practical Medical Center of Cardiology | Not applicable | Not yet recruiting | Nov 10, 2026 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Sep 17, 1940 | BensulfoidNDA 2918 | Poythress | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA